Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Cervical cancer screening”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed2026

HPV Testing Versus Cytology for Cervical Cancer Screening Among Women 50 Years and Older: Evidence From the HPV FOCAL Randomized Controlled Trial.

Evidence on the comparative effectiveness of HPV testing versus cytology specifically in women aged ≥ 50 years who are approaching screening cessation remains limited. This analysis included 6471 women aged ≥ 50 at baseline screening in the HPV FOCAL randomized clinical trial. Women were randomly allocated to receive cytology (Control Group, n = 3248, 50.19%) or HPV testing (Intervention Group, n = 3223, 49.81%) at baseline, with co-testing at 48-month exit. We calculated incidence rates and risk ratios for CIN2+ detection over follow-up and compared missed lesions at exit by screening method. At the 48-month exit, CIN2+ detection was lower among HPV baseline-negative women than among those in the cytology group (1.61/1000 [95% CI, 0.52-3.76] vs. 3.15/1000 [95% CI, 1.51-5.78]; risk ratio, 0.51 [95% CI, 0.11-0.91]), reflecting higher baseline detection with HPV testing and fewer prevalent lesions at exit. Even with cytology re-screening at 2 years, 50% of CIN2+ cases were missed compared to 30% with HPV testing. After adjusting for age, education, smoking status, and lifetime sexual partners, the hazard ratio for CIN2+ comparing HPV to cytology was 0.44 (95% CI, 0.22-0.88). Among women aged ≥ 50 years, HPV primary screening was more effective than cytology at detecting CIN2+ lesions and was associated with a continued lower subsequent risk following a negative HPV test, supporting its use in cervical cancer screening programs in this age cohort.

Aged↗
PubMed1976

Ages and frequencies for cervical cancer screening.

A simple method of calculating the best ages for carrying out cervical cytology screening procedures is proposed. The argument is graphical, the outcomes are readily understood by visual and intuitive methods, but a computer program for assisting the calculations is constructed. Use of the method indicates that relatively high rates of screening should be employed in women over 45, and that routine screening in women under 30 years of age is likely to be ineffective in reducing mortality. The method predicts that, if we assume a negative error rate for the test of 0-2, and a natural history with a mean interval between detectability and incurability of about 6 years, a series of 10 tests deployed between 35 and 80 years in England and Wales should give a yield of 0-67 deaths saved per 1000 tests performed, and should be capable of saving about 77% of all deaths from cervical cancer in women who conform with the recommendation.

Adult↗
PubMed1976

Automation in cervical cancer screening. Part 1: fixed cell scanning systems.

Cytology automation is highly desirable if a mass cancer screening system is to be effective, and has been the subject of widespread research and development effort. Several experimental systems have been developed based on fixed cell scanning or flow techniques, but clinical trials have produced disappointing results. The major problem with these early systems has been that of false positive "abnormal cell" signals caused by cell overlaps and artifacts. Most current research is devoted to the development of better techniques for cell presentation, to the improvement of pattern recognition techniques, and to the exploitation of novel cell parameters in flow systems.

Automation↗
PubMedDate not supplied

A sample preparation for automated cervical cancer screening.

A procedure for cluster disruption, cell dispersal and the production of a monolayer of cells from fluid suspensions for automated cell-scanning machines in an interactive system has been developed. The combination of 0.1 per cent dithiothreitol and 40 per cent alcohol in a balanced salt solution provides a self-limiting form of mucolysis which is completed by a controlled syringing regime to produce an optimally dispersed cell sample without the production of cell debris from the more effete cells. The induction of a positive charge on a microscope slide to attract the negatively charged cells has been achieved by coating the slides with the cationic polymer, polylysine. The cells appear to be sufficiently well attached to permit wet fixation and subsequent stain processing without loss. Quantitative data is given to demonstrate the superior cell presentation that is achieved by this new technique for automated scanning.

Diagnosis, Differential↗
PubMed1978

Efficacy of screening for cervical cancer: a review.

Cytologic screening for cervical cancer currently enjoys wide acceptance, but there remains controversy in the literature concerning its efficacy in prolonging life. On the basis of a literature review, several conclusions are reached: 1) Cervical screening can identify women who are at greater-than-average risk of developing invasive cervical cancer by detecting asymptomatic lesions that would frequently progress to invasion if left untreated; 2) Therapy based on confirmed positive smears can reduce the incidence and mortality rates of invasive cervical cancer, as shown by declining rates in many centers that had constant or increasing rates before screening began, lower rates for geographic areas and occupational groups having less screening, and lower rates among screened women than unscreened women; and 3) Attempts to estimate the amount of life prolongation attributable to cervical screening have not yet yielded reliable figures, because of difficulties with the models or data used. However, in view of the available evidence, it is suggested that incomplete data should not prevent a vigorous continuation of screening where it is already extensive, and an escalation where it is not.

Adolescent↗
PubMed1977

Selective screening for cervical cancer. Experience of the Finnish mass screening system.

Names of women eligible to be screened for cervical cancer are taken from the national population registry and the women are invited by a personal letter. The data, from these mass screenings are analysed and stored at the screening registry. To reduced the costs of the system and to increase the yield of preinvasive lesions the idea of selective screening was considered. Tt was decided that if people were selected according to their risk factors, as recorded in the national population registry, the screening would be ineffective as many cases of invasive cancer were found in the low risk groups. High risk factors were determined from anamnestic data on systems and from previous cytological diagnoses. The proportion of women with symptoms of bleeding or the class II-V smears without positive histological results constituted fewer than 10% of the participants, but 20% and 40% respectively of invasive carcinomas were found in these groups during the subsequent follow-up period. Thus it is suggested that selective screening apart from that based on age has a limited application and should be restricted mainly to the interval between the organised screenings, which in Finland is five years.

Adult↗
PubMed1976

Colposcopy screening for cervical cancer in a family planning program.

A brief history is presented of colposcopy in the United States and at Louisiana State University. Incorporation of colposcopy screening as a part of the cervical cancer screening program in the Louisiana Family Planning Program is discussed, and the reasons for the need of "in house" colposcopy service are outlined. Data of the Louisiana Family Planning Program Colposcopy Service for the three-year period 1972 through 1974 are presented. Analysis of these data reveals that cytology when used without colposcopy fails to reveal the presence of major cervical pathology in 30.2% of patients. It is concluded that colposcopic screening must be a part of all family planning and cervical cancer detection programs.

Colposcopy↗
PubMed1979

Preselection of alarms in a hybrid system for screening of cervical cancer.

In this report, a preselection of alarms in a system for automated screening of cervical cancer based on depositing the cell sample linearly as a "cell trace" on a tape and analyzing it at different decision levels with increasing complexity, and preliminary results on analyzing cervical material with this system are discussed. The "cell trace" is analyzed with the slit-scan technique. Six parameters are computed: 1) cellular diameter; 2) nuclear diameter; 3) nuclear fluorescence (acriflavin-Feulgen) as nuclear DNA; 4) cellular fluorescence; 5) nuclear to cytoplasm ratio (N/C ratio); and 6) nuclear density. At present, only nuclear fluorescence is used to define a decision boundary between normal and potentially atypical cells. Under this criteria the slit-scan analysis leaves 5% of the events in a sample that must be rechecked at a second decision level in normal cell samples. A further reduction is expected when several slit-scan parameters are used at the first decision step. All events declared suspicious will be investigated in more detail by a two dimensional image analyzing system where the fluorescence image is generated by a laser scanning system. Results obtained in preliminary experiments are discussed in this paper.

Computers↗